Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity59
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials42
Management of Acute Liver Failure: Update 202240
Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment39
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities33
Hepatic Alveolar Echinococcosis32
Interleukin-17 in Liver Disease Pathogenesis31
Cellular Senescence in Liver Disease and Regeneration30
Aging and Chronic Liver Disease28
Early Diagnosis and Prevention of Infections in Cirrhosis24
Molecular Mechanisms of Hepatoblastoma23
The Role of Liver Zonation in Physiology, Regeneration, and Disease22
Nonalcoholic Fatty Liver Disease: Current Global Burden21
Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma20
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update20
Plasma Exchange in Acute and Acute on Chronic Liver Failure19
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives17
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination17
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis16
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone16
Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers15
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury15
Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review15
Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management15
Wearables, Physical Activity, and Exercise Testing in Liver Disease14
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)—Multi-Omic and Singulomic Approaches14
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma14
Shared Mechanisms between Cardiovascular Disease and NAFLD13
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer13
Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases13
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure13
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review12
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease12
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD11
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?11
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?11
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems11
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy10
The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors10
Organoids for the Study of Liver Cancer10
Circadian Regulation of Gene Expression and Metabolism in the Liver10
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics10
Role of YAP1 Signaling in Biliary Development, Repair, and Disease9
The Neglected Role of Bile Duct Epithelial Cells in NASH9
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies8
Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective8
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma8
Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations8
Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis8
Management of Portal Vein Thrombosis in Cirrhosis8
Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD8
0.060271024703979